Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bleeding Profile With Continuous Hormone Replacement Therapy in Postmenopausal Women: A Prospective, Open, Multicenter Trial of Activelle® Treatment Following Switch From Trisekvens®

NCT01705249 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01705249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01705249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bleeding Profile With Continuous Hormone Replacement Therapy in Postmenopausal Women: A Prospective, Open, Multicenter Trial of Activelle® Treatment Following Switch From Trisekvens®
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
August 14, 2001
Completion date
June 6, 2003
Enrollment
191 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, menopause